Institutional Biosafety Committee
Risk Assessment for use of Engineered Genetic Materials in Clinical Research
Learn why an institutional biosafety committee needs to complete a risk assessment for engineered genetic material in clinical research.
Safe Sharps Handling When Dispensing Investigational Products
Care must be taken to avoid sharps-related injuries and exposures when preparing investigational products for clinic transportation.
A Changing World in Gene Therapy Research: Exciting Opportunities for Medical Advancement and Biosafety Challenges
Our IBC experts authored the article “A Changing World in Gene Therapy Research: Exciting Opportunities for Medical Advancement and Biosafety...
Q&A Part 1 – Gene Therapy Research in the Age of COVID-19
Panelists from Advarra’s inaugural virtual symposium participated in a Q&A session to address questions submitted by the audience. Read part 1:
Q&A Part 2 – Gene Therapy Research in the Age of COVID-19
Expert panelists from Advarra’s gene therapy virtual symposium address some of the most popular questions submitted by the audience. Read part 2:
Safety Precautions for Laboratory Research With COVID-19 Specimens
The pandemic has brought biosafety to the spotlight. This blog discusses guidelines and safety precautions for handling COVID-19 specimens.
Virtual Symposium: Gene Therapy Research in the Age of COVID-19
The coronavirus pandemic has brought genetic research to the forefront. To address emerging issues, Advarra presents its first virtual symposium. Read more: